secwatch.observer — SEC 8-K summary
======================================

Issuer:     WEST PHARMACEUTICAL SERVICES INC (WST)
CIK:        0000105770
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0000105770-24-000088
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

West Pharmaceutical authorizes repurchase of up to 550,000 shares
-----------------------------------------------------------------

- Board approved new share repurchase program on Dec 9, 2024, authorizing up to 550,000 shares.
- Repurchases may be made on open market or in private transactions under Rule 10b-18.
- Program expected to be completed by December 31, 2025.
- Existing repurchase program expires at end of 2024.
- Repurchase timing and number depend on market conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000088/0000105770-24-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/105770/000010577024000088/wst-20241209.htm
  HTML page:      https://secwatch.observer/filing/0000105770-24-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer